Classification of mild cognitive impairment and alzheimer disease using model-based MR and magnetization transfer imaging

American Journal of Neuroradiology

Volumn 34, Issue 4, 2013, Pages 740-746

  Wiest, R ^a   Burren, Y ^a,c   Hauf, M ^a   Schroth, G ^a   Pruessner, J ^d   Zbinden, M ^a   Cattapan Ludewig, K ^b,c   Kiefer, C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b KJPD Psychiatric University   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; INSULA; MALE; MILD COGNITIVE IMPAIRMENT; MODEL BASED MAGNETIZATION TRANSFER; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CLUSTER ANALYSIS; ENTORHINAL CORTEX; FEASIBILITY STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; TEMPORAL LOBE;

EID: 84876744401     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3307     Document Type: Article

References (37)

1. Roe CM, Fitzpatrick AL, Xiong C, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2010;74:106-12
2. Dickerson BC, Stoub TR, Shah RC, et al. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 2011;76:1395-402
3. Haller S, Lovblad KO, Giannakopoulos P. Principles of classification analyses in mild cognitive impairment (MCI) and Alzheimer disease. J Alzheimers Dis 2011;26(suppl 3):389-94
4. Chupin M, Hammers A, Liu RS, et al. Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: Method and validation. Neuroimage 2009;46:749-61
5. Calvini P, Chincarini A, Gemme G, et al. Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease. Med Phys 2009;36:3737-47
6. Whitwell JL, Shiung MM, Przybelski SA, et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 2008;70:512-20 (Pubitemid 351653375)
7. Chincarini A, Bosco P, Calvini P, et al. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease. Neuroimage 2011;58:469-80
8. Jack CR Jr. Alzheimer disease: New concepts on its neurobiology and the clinical role imaging will play. Radiology 2012;263:344-61
9. Kabani NJ, Sled JG, Shuper A, et al. Regional magnetization transfer ratio changes in mild cognitive impairment. Magn Reson Med 2002; 47:143-48 (Pubitemid 34019703)
10. van der Flier WM, van den Heuvel DM, Weverling-Rijnsburger AW, et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 2002;52: 62-67 (Pubitemid 34693744)
11. Ropele S, Schmidt R, Enzinger C, et al. Longitudinal magnetization transfer imaging in mild to severe Alzheimer disease. AJNR Am J Neuroradiol 2012;33:570-75
12. Stanisz GJ, Yoon RS, Joy ML, et al. Why does MTR change with neuronal depolarization? Magn Reson Med 2002;47:472-75 (Pubitemid 34194001)
13. Sled JG, Pike GB. Quantitative imaging of magnetization transfer exchange and relaxation properties in vivo using MRI. Magn Reson Med 2001;46:923-31 (Pubitemid 33019916)
14. Stanisz GJ, Odrobina EE, Pun J, et al. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005;54:507-12
15. Kiefer C, Brockhaus L, Cattapan-Ludewig K, et al. Multi-parametric classification of Alzheimer's disease and mild cognitive impairment: The impact of quantitative magnetization transfer MR imaging. Neuroimage 2009;48:657-67
16. Giulietti G, Bozzali M, Figura V, et al. Quantitative magnetization transfer provides information complementary to grey matter atrophy in Alzheimer's disease brains. Neuroimage 2012;59:1114-22
17. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44 (Pubitemid 14076461)
18. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183-94 (Pubitemid 39222988)
19. Jeon YH, Sansoni J, Low LF, et al. Recommended measures for the assessment of behavioral disturbances associated with dementia. Am J Geriatr Psychiatry 2011;19:403-15
20. McKhann GM. Changing concepts of Alzheimer disease. JAMA 2011;305:2458-59
21. MacFall JR, Wehrli FW, Breger RK, et al. Methodology for the measurement and analysis of relaxation times in proton imaging. Magn Reson Imaging 1987;5:209-20 (Pubitemid 17136476)
22. Haase A. Snapshot FLASH MRI: Applications to T1, T2, and chemical-shift imaging. Magn Reson Med 1990;13:77-89 (Pubitemid 20084545)
23. Deichmann R, Adolf H, Kuchenbrod E, et al. Compensation of diffusion effects in T2 measurements. Magn ResonMed1995;33:113-15
24. Deichmann R, Adolf H, Noth U, et al. Fast T2-mapping with snapshot flash imaging. Magn Reson Imaging 1995;13:633-39
25. Bobinski M, de Leon MJ, Wegiel J, et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000;95: 721-25
26. Mosconi L, Brys M, Glodzik-Sobanska L, et al. Early detection of Alzheimer's disease using neuroimaging. Exp Gerontol 2007;42: 129-38 (Pubitemid 44937821)
27. Fennema-Notestine C, Hagler DJ Jr, McEvoy LK, et al. Structural MRI biomarkers for preclinical and mild Alzheimer's disease.Hum Brain Mapp 2009;30:3238-53
28. Walhovd KB, Fjell AM, Dale AM, et al. Multi-modal imaging predicts memory performance in normal aging and cognitive decline. Neurobiol Aging 2010;31:1107-21
29. Teslic L, Hartmann B, Nelles O, et al. Nonlinear system identification by Gustafson-Kessel fuzzy clustering and supervised local model network learning for the drug absorption spectra process. IEEE Trans Neural Netw 2011;22:1941-51
30. Ridha BH, Tozer DJ, Symms MR, et al. Quantitative magnetization transfer imaging in Alzheimer disease. Radiology 2007;244:832-37 (Pubitemid 47292095)
31. Paajanen T, Hanninen T, Tunnard C, et al. CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: The AddNeuroMed study. J Alzheimers Dis 2010;22:1089-97
32. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
33. Braak H, Braak E. Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging 1994;15:355-56, discussion 379-80 (Pubitemid 24194878)
34. Braak H, Thal DR, Ghebremedhin E, et al. Stages of the pathologic process in Alzheimer disease: Age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011;70:960-69
35. Stranahan AM, Mattson MP. Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer's disease. Neural Plast 2010:2010;108190
36. Cuingnet R, Gerardin E, Tessieras J, et al. Automatic classification of patients with Alzheimer's disease from structural MRI: A comparison of ten methods using the ADNI database. Neuroimage 2011;56: 766-81
37. Wilkosz PA, Seltman HJ, Devlin B, et al. Trajectories of cognitive decline in Alzheimer's disease. Int Psychogeriatr 2010;22:281-90